Jan 4 (Reuters) - The New York Stock Exchange is reconsidering its plan to allow three Chinese telecom giants to remain listed, the latest twist to a saga amid confusion over rules set by the Trump administration and tension within Washington on China policy.
If it does so, it would mar
Thanks for contacting us. We've received your submission.
House Minority Leader Kevin McCarthy is committed to further exploring the findings of special counsel John Durham’s investigation into the FBI’s Trump-Russia probe to “ensure nothing like it ever happens again.
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued sup
Get the best experience and stay connected to your community with our Spectrum News app. Learn More
Get hyperlocal forecasts, radar and weather alerts.
Please enter a valid zipcode.
Here are the AP’s latest coverage plans, top stories and promotable content. All times EDT.
Hi, what are you looking for?
The Supplemental Health Insurance 2022-2028 report covers evaluating the risk factors and opportunity of industry, sales channels, also report gives the information about basic types, global regions and applications, This report also provides in-depth inform
Getting a good measurement is a matter of using the right tool for the job. A tape measure and a caliper are both useful tools, but they’re hardly interchangeable for every task. Some jobs call for a hands-off, indirect way to measure small distances, which is where this image analysis m
There is growing public awareness about the scope of China’s surveillance and repression activities in Xinjiang, but its scale continues to defy the imagination.
Chinese authorities have detained over 1.1 million ethnic Uighurs, representing about 10% of the Uighur population, a Turkic
Expert insights, analysis and smart data help you cut through the noise to spot trends, risks and opportunities.
Join over 300,000 Finance professionals who already subscribe to the FT.
Then AU$75 per month New customers only Cancel anytime during yo
The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo
FRANKFURT, May 11 (Reuters) - Development of a new cancer treatment pioneered by Roche (ROG.S) was thrown into doubt on Wednesday when the immunotherapy